Über das Unternehmen
- Firmenname (rechtlich): Sichuan Chenghua Bio-technology Co., Ltd
- Registrierungsland: China
- Adresse: 733 Furong Avenue Section 2, Chengdu, • Sichuan
- Anzahl der Mitarbeiter: 25 - 49
Beschreibung:
Sichuan Chenghua Bio-Technology Co., Ltd. is a high-tech corporation engaged in drug declaration and manufacture of pharmaceuticals and intermediates, earning a good reputation at home and abroad through advanced technology, standardized management and a well-established service system. The company mainly produces UDCA, CDCA, Obeticholic Acid and their intermediates, Isavuconazonium Sulfate and intermediates, Posaconazole and intermediates, Omadacycline and intermediates, and other cholic acid products.
Geschäftsaktivitäten
Biologische & Fermentationsrohstoffe
Hersteller
Pharmazeutische Wirkstoffe (API)
API-Hersteller
Pharmazeutische Chemikalien
HerstellerRohstofflieferant
Absatzmärkte
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Northern America: Bermuda, Canada, Greenland, Saint Pierre and Miquelon, United States
Hauptprodukte/-dienstleistungen
- Pharmazeutische Wirkstoffe (API): Active Pharmaceutical Ingredients
- Pharmazeutische Chemikalien: (2S,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanenitrile, Pharmaceutical Intermediates, Tauroursodeoxycholic acid, Chenodeoxycholic Acid ( CDCA), Posaconazole intermediate （POA）, Isavuconazonium sulfate, Obeticholic Acid Intermediate A, UDCA（ursodeoxycholic acid）, Omadacycline and intermediates
Unsere Produkte & Dienstleistungen
Certifications
Proofs
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
Bewertungen
(0)
(0)
(0)
(0)
(0)
Kommentare
Filter:
Sortieren nach:
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen